Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 15/20 | 0.50 |
| ▸ | CA1 | P00915 | 14/20 | 0.48 |
| ▸ | MMP1 | P03956 | 5/20 | 0.48 |
| ▸ | MMP2 | P08253 | 5/20 | 0.48 |
| ▸ | MMP9 | P14780 | 5/20 | 0.48 |
| ▸ | MMP8 | P22894 | 5/20 | 0.48 |
| ▸ | MMP13 | P45452 | 5/20 | 0.48 |
| ▸ | F2 | P00734 | 4/20 | 0.43 |
| ▸ | PRSS1 | P07477 | 4/20 | 0.43 |
| ▸ | PRSS2 | P07478 | 4/20 | 0.43 |
| ▸ | PRSS3 | P35030 | 4/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1395624 | 0.91 | CA2 (0.40) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL1395644 | 0.78 | CA2 (0.39) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL774916 | 0.75 | CA2 (0.55) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL73684 | 0.73 | CA2 (0.52) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL14472110 | 0.73 | — | — | |
| SCHEMBL455847 | 0.73 | CA2 (0.52) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL9335744 | 0.73 | CA2 (0.59) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL740209 | 0.71 | CA2 (0.50) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL14471945 | 0.71 | CA2 (0.33) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL2021790 | 0.71 | CA2 (0.50) | CA2CA1MMP1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111051278-B | Method for producing perfluoroalkyl sulfimide metal salt | 中央硝子株式会社 | 2022-05-13 | — | — | CN | disclosed |
| CN-111051278-A | Method for producing perfluoroalkyl sulfimide metal salt | 中央硝子株式会社 | 2020-04-21 | — | — | CN | disclosed |
| EP-2543663-B1 | PREPARATION METHOD FOR PERFLUOROALKANE SULFINATE | CENTRAL GLASS CO LTD (JP) | 2017-10-11 | — | — | EP | disclosed |
| US-9073828-B2 | Preparation method for perfluoroalkane sulfinate | CENTRAL GLASS COMPANY, LIMITED (JP) | 2015-07-07 | — | — | US | disclosed |
| EP-2289875-B1 | PROCESS FOR PRODUCING PERFLUOROALKANESULFINIC ACID SALT | CENTRAL GLASS CO LTD (JP) | 2013-04-10 | — | — | EP | disclosed |
| US-20130023695-A1 | Preparation Method for Perfluoroalkane Sulfinate | CENTRAL GLASS COMPANY, LIMITED (JP) | 2013-01-24 | — | — | US | disclosed |
| EP-2543663-A1 | PREPARATION METHOD FOR PERFLUOROALKANE SULFINATE | Central Glass Company, Limited (JP) | 2013-01-09 | — | — | EP | disclosed |
| EP-2289875-A1 | PROCESS FOR PRODUCING PERFLUOROALKANESULFINIC ACID SALT | Central Glass Company, Limited (JP) | 2011-03-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130023695-A1 | Preparation Method for Perfluoroalkane Sulfinate | PFAS, PFKFB1, PFKFB2 | CA2 306/4885CA1 380/4885MMP1 2604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.